Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0403981049616218 | N/A |
Market Cap | $5.36M | N/A |
Shares Outstanding | 132.70M | N/A |
Employees | 0 | N/A |